WuXi Biologics (Cayman) Inc. (WXXWY)
OTCMKTS · Delayed Price · Currency is USD
8.42
-0.30 (-3.44%)
At close: Dec 26, 2025
WuXi Biologics Employees
WuXi Biologics had 12,575 employees as of December 31, 2024. The number of employees decreased by 165 or -1.30% compared to the previous year.
Employees
12,575
Change (1Y)
-165
Growth (1Y)
-1.30%
Revenue / Employee
$223,025
Profits / Employee
$46,667
Market Cap
17.31B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12,575 | -165 | -1.30% |
| Dec 31, 2023 | 12,740 | 367 | 2.97% |
| Dec 31, 2022 | 12,373 | 2,509 | 25.44% |
| Dec 31, 2021 | 9,864 | 3,218 | 48.42% |
| Dec 31, 2020 | 6,646 | 980 | 17.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| OpGen | 1 |
WuXi Biologics News
- 3 days ago - WuXi Biologics Recognized by Hong Kong ESG Reporting Awards 2025 for Outstanding ESG Disclosure - PRNewsWire
- 8 days ago - WuXi Biologics Achieves CDP Highest "A" Ratings in Both Climate Change and Water Security - PRNewsWire
- 25 days ago - WuXi Biologics Extends Global CRDMO Network to Qatar Through Strategic MoU Signed with Qatar Free Zones Authority - PRNewsWire
- 25 days ago - WuXi Biologics Signs MoU With Qatar Free Zones Authority To Set Up Middle East CRDMO Center - Nasdaq
- 2 months ago - WuXi Biologics Included in Hang Seng Corporate Sustainability Benchmark Index - PRNewsWire
- 2 months ago - WuXi Biologics Honored with 2025 Global Customer Value Leadership Recognition by Frost & Sullivan - PRNewsWire
- 2 months ago - WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year - PRNewsWire
- 3 months ago - WuXi Biologics Launches WuXia™4.0, Targeted Integration Cell Line Platform TrueSite TI™,to Accelerate Biologics Development with High Titer and Superior Stability - PRNewsWire